|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-22
|
|
pubmed:abstractText |
Only 20-30% of elderly patients with acute lymphoblastic leukemia (ALL) are enrolled in clinical trials because of co-morbid disorders or poor performance status. We present the results of treatment of Philadelphia chromosome-negative (Ph-) ALL patients over 55 yr treated in the PETHEMA ALL-96 trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/6-Mercaptopurine,
http://linkedlifedata.com/resource/pubmed/chemical/Asparaginase,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Teniposide,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
pubmed-author:AbellaEugeniaE,
pubmed-author:BethencourtConcepciónC,
pubmed-author:BrunetSalutS,
pubmed-author:DebénGuillermoG,
pubmed-author:FeliuEvaristE,
pubmed-author:Hernández-RivasJesús-MaríaJM,
pubmed-author:LópezRamónR,
pubmed-author:MorgadesMireiaM,
pubmed-author:NovoAndrésA,
pubmed-author:OriolAlbertA,
pubmed-author:OrtínXavierX,
pubmed-author:Ortega-RivasFernandoF,
pubmed-author:PETHEMA Group,
pubmed-author:PascuttoCristianaC,
pubmed-author:RiberaJosep-MariaJM,
pubmed-author:SanzMiguel-AngelMA,
pubmed-author:TormoMarM,
pubmed-author:XicoyBlancaB,
pubmed-author:del PotroEloyE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
102-10
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17087744-6-Mercaptopurine,
pubmed-meshheading:17087744-Aged,
pubmed-meshheading:17087744-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17087744-Asparaginase,
pubmed-meshheading:17087744-Comorbidity,
pubmed-meshheading:17087744-Cyclophosphamide,
pubmed-meshheading:17087744-Cytarabine,
pubmed-meshheading:17087744-Daunorubicin,
pubmed-meshheading:17087744-Dexamethasone,
pubmed-meshheading:17087744-Disease-Free Survival,
pubmed-meshheading:17087744-Female,
pubmed-meshheading:17087744-Follow-Up Studies,
pubmed-meshheading:17087744-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17087744-Humans,
pubmed-meshheading:17087744-Kaplan-Meier Estimate,
pubmed-meshheading:17087744-Male,
pubmed-meshheading:17087744-Methotrexate,
pubmed-meshheading:17087744-Middle Aged,
pubmed-meshheading:17087744-Neutropenia,
pubmed-meshheading:17087744-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:17087744-Prednisone,
pubmed-meshheading:17087744-Prognosis,
pubmed-meshheading:17087744-Remission Induction,
pubmed-meshheading:17087744-Severity of Illness Index,
pubmed-meshheading:17087744-Survival Analysis,
pubmed-meshheading:17087744-Teniposide,
pubmed-meshheading:17087744-Treatment Outcome,
pubmed-meshheading:17087744-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
|
|
pubmed:affiliation |
Clinical Hematology Department, Institut Catalá d'Oncologia-Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
